Tianshui Sun
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination.
Journal: Clinical and translational medicine
Published: August 03, 2024
METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.
Journal: Cell communication and signaling : CCS
Published: October 30, 2021
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
Journal: Molecular oncology
Published: April 17, 2021
METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Journal: Journal of translational medicine
Published: February 05, 2021
PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells.
Journal: Frontiers in oncology
Published: December 17, 2020
TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway.
Journal: Journal of translational medicine
Published: November 06, 2020
The role of ubiquitination and deubiquitination in cancer metabolism.
Journal: Molecular cancer
Published: July 15, 2020
SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.
Journal: Aging
Published: February 05, 2020
Chemoresistance-associated alternative splicing signatures in serous ovarian cancer.
Journal: Oncology letters
Published: July 15, 2019
Epidemiological characteristics of severe fever with thrombocytopenia syndrome in Liaoning province, 2010-2013
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: April 01, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026